Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling Matthew D. ThompsonDaniel A. BeardFan Wu Original Paper 26 May 2012 Pages: 313 - 327
Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1 Hee-Doo YooHea-Young ChoYong-Bok Lee Original Paper 24 May 2012 Pages: 329 - 341
General relationship between transit compartments and lifespan models Gilbert KochJohannes Schropp Original Paper 23 June 2012 Pages: 343 - 355
From in vitro EC50 to in vivo dose–response for antiretrovirals using an HIV disease model. Part I: A framework Jing FangPravin R. Jadhav Original Paper 27 June 2012 Pages: 357 - 368
From in vitro EC50 to in vivo dose–response for antiretrovirals using an HIV disease model. Part II: Application to drug development Jing FangPravin R. Jadhav Original Paper 08 July 2012 Pages: 369 - 381
A reduction in between subject variability is not mandatory for selecting a new covariate Chakradhar V. LagishettyPavan VajjahStephen B. Duffull Original Paper 06 July 2012 Pages: 383 - 392
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building Eric A. ShererMark E. SaleRobert R. Bies Original Paper Open access 06 July 2012 Pages: 393 - 414